A Description of Mortality Associated with IPT plus ART Compared to ART Alone among HIV-Infected Individuals in Addis Ababa, Ethiopia: A Cohort Study

PloS One
Dumessa Edessa, Jimma Likisa

Abstract

Tuberculosis (TB) is the most common human immunodeficiency virus (HIV) associated opportunistic infection. It is the leading cause of death in HIV-infected individuals in sub-Saharan Africa. Anti-retroviral therapy (ART) and isoniazid preventive therapy (IPT) are the two useful TB preventative strategies available to reduce TB among people living with HIV (PLHIV). Therefore, the aim of this study is to compare mortality associated with IPT taken together with ART, as well as ART alone, among PLHIV. A retrospective cohort study was undertaken at Tikur Anbessa Specialized Hospital (TASH) and Zewditu Memorial Hospital (ZMH) on 185 patients receiving IPT (6 months) plus ART and 557 patients receiving ART alone. Mortality rates (MR) per 100 person-years (PYs) were used to compare mortality rates amongst the groups. Time-to-death and survival probabilities of the patients were determined using the Kaplan Meier Method. The Cox Proportional Hazard Model was employed to estimate the effect of IPT plus ART on survival of PLHIV. The mortality cases noted in patients treated by IPT plus ART versus ART alone were 18 (4.5 cases/100 PYs) and 116 (10 cases/100 PYs), respectively. In reference to the ART alone, the IPT plus ART reduced the lik...Continue Reading

References

Sep 21, 1995·The New England Journal of Medicine·R E ChaissonR D Moore
Apr 25, 2000·Postgraduate Medical Journal·A ZumlaJ M Grange
Nov 28, 2001·JAMA : the Journal of the American Medical Association·R S HoggJ S Montaner
Aug 24, 2004·AIDS·Maria I B NemesMaria F M Souza
Dec 20, 2005·Tropical Medicine & International Health : TM & IH·Ludwig ApersRobert Colebunders
May 18, 2006·Emerging Infectious Diseases·Maria Elvira BalcellsAlison D Grant
Jul 6, 2006·JAMA : the Journal of the American Medical Association·Bridget M Kuehn
Aug 10, 2006·JAMA : the Journal of the American Medical Association·Edward J MillsDavid R Bangsberg
Nov 14, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Geetanjali ChanderRichard D Moore
Mar 30, 2007·Journal of Internal Medicine·D B Meya, K P W J McAdam
Aug 30, 2007·The Journal of Infectious Diseases·Gavin J ChurchyardRichard E Chaisson
Feb 20, 2008·Tropical Medicine & International Health : TM & IH·Solomon Chih-Cheng ChenJung-Der Wang
Jun 24, 2009·Memórias do Instituto Oswaldo Cruz·Claudia Teresa Vieira de SouzaSonia Regina Lambert Passos
Apr 20, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gabriel ChamieDiane V Havlir
May 11, 2010·Bulletin of the World Health Organization·B J Marais, P D van Helden
Oct 12, 2010·Clinical & Developmental Immunology·Stephen D LawnRobert J Wilkinson
Jan 1, 2009·Evidence-based Child Health : a Cochrane Review Journal·Hoosen CoovadiaTony Walls
Jan 7, 2011·PloS One·Masja StraetemansMarieke J van der Werf
Jul 8, 2011·The New England Journal of Medicine·Shabir A MadhiUNKNOWN P1041 Study Team
Mar 1, 2012·PLoS Pathogens·Andrzej PawlowskiGunilla Källenius

❮ Previous
Next ❯

Methods Mentioned

BETA
chest
X-ray

Software Mentioned

SPSS
Epi

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
D M GrayH J Zar
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
S ZaehA Tenna
© 2021 Meta ULC. All rights reserved